1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Tiziano Frateschi
Tiziano Frateschi
Articles (2574)  | Author's Website |

Kahn Brothers Cuts Merck & Co., Hologic

Firm's largest sales of the 2nd quarter

Kahn Brothers (Trades, Portfolio) manages a $592 million equity portfolio composed of 47 stocks as of the quarter's end. The firm sold shares of the following stocks during the second quarter of 2020.

Merck & Co.

The fund trimmed its position in Merck & Co Inc. (MRK) by 10.15%. The trade had an impact of -1.43% on the portfolio.

d9d812da7c3488496583ef3dff4a5eeb.png

The company has a market cap of $27.92 billion and an enterprise value of $39.24 billion.

GuruFocus gives the company a profitability and growth rating of 7 out of 10. The return on equity of 106.44% and return on assets of 3.71% are outperforming 70% of companies in the travel and leisure industry. Its financial strength is rated 4 out of 10. The cash-debt ratio of 0.14 is below the industry median of 0.42.

The largest guru shareholder of the company is PRIMECAP Management (Trades, Portfolio) with 0.33% of outstanding shares, followed by Steven Romick (Trades, Portfolio)’s FPA Crescent Fund with 0.28% and First Pacific Advisors (Trades, Portfolio) with 0.15%.

Hologic

The fund reduced its Hologic Inc. (HOLX) holding by 69.04%. The portfolio was impacted by -1.18%.

ef0493b3fcb7e934d4f7b9efaed7df82.png

The company operates in the following segments: breast health, diagnostics, surgical and skeletal health. It has a market cap of $18.66 billion and an enterprise value of $21.24 billion.

GuruFocus gives the company a profitability and growth rating of 6 out of 10. The return on equity of 22.74% and return on assets of 7.55% are outperforming 77% of companies in the medical devices and instruments industry. Its financial strength is rated 4 out of 10. The cash-debt ratio of 0.22 is below the industry median of 1.65.

The largest guru shareholder of the company is Larry Robbins (Trades, Portfolio)’ Glenview Capital with 1.51% of outstanding shares, followed by the Vanguard Health Care Fund (Trades, Portfolio) with 0.71% and Pioneer Investments (Trades, Portfolio) with 0.68%.

GlaxoSmithKline

The fund curbed its position in GlaxoSmithKline PLC (GSK) by 1.66%. The portfolio was impacted by -0.18%.

867d8ebaff2eba427445c28e488c885c.png

The pharmaceutical company has a market cap of $103.46 billion and an enterprise value of $142.68 billion.

GuruFocus gives the company a profitability and growth rating of 8 out of 10. The return on equity of 62.45% and return on assets of 8.44% are outperforming 79% of companies in the drug manufacturers industry. Its financial strength is rated 4 out of 10. The cash-debt ratio of 0.26 is below the industry median of 0.87.

Some notable guru shareholders are Dodge & Cox with 1.76% of outstanding shares, Jim Simons (Trades, Portfolio)’ Renaissance Technologies with 0.92% and Ken Fisher (Trades, Portfolio) with 0.62%.

MBIA

The fund reduced its position in MBIA Inc. (MBI) by 2.35%, impacting the portfolio by -0.17%.

cfe2167810659cea2160aacd25937b70.png

The financial guaranty insurance provider has a market cap of $541.60 million and an enterprise value of $4.42 billion.

GuruFocus gives the company a profitability and growth rating of 3 out of 10. The return on equity of -73.8% and return on assets of -8.67% are underperforming 99% of companies in the insurance industry. Its financial strength is rated 2 out of 10. The cash-debt ratio of 0.05 is below the industry median of 2.28.

The largest guru shareholder of the company is Kahn Brothers (Trades, Portfolio) with 7.36% of outstanding shares, followed by Simons’ firm with 1.16% and Francis Chou (Trades, Portfolio) with 0.96%.

Seaboard

The investment fund curbed its holding in Seaboard Corp. (SEB) by 2.05%. The trade had an impact of -0.13% on the portfolio.

e262d959945cf21d067ca2f9870d1800.png

The company has a market cap of $3.15 billion and an enterprise value of $3.36 billion.

GuruFocus gives the company a profitability and growth rating of 6 out of 10. The return on equity of 1.14% and return on assets of 0.65% are underperforming 59% of companies in the conglomerates industry. Its financial strength is rated 7 out of 10. The cash-debt ratio of 0.86 is above the industry median of 0.42.

Other notable guru shareholders include Simons’ firm with 0.6% of outstanding shares, Diamond Hill Capital (Trades, Portfolio) with 0.24% and Third Avenue Management (Trades, Portfolio) with 0.15%.

New York Community Bancorp

The investment fund cut its New York Community Bancorp Inc. (NYCB) position by 1.37%. The trade had an impact of -0.12% on the portfolio.

d12d9a704d5f3be710530071c2a5763d.png

The multi-bank holding company has a market cap of $4.64 billion and an enterprise value of $18.23 billion.

GuruFocus gives the company a profitability and growth rating of 3 out of 10. The return on equity of 5.53% and return on assets of 0.76% are underperforming 70% of companies in the banks industry. Its financial strength is rated 2 out of 10. The cash-debt ratio of 0.09 is below the industry median of 1.34.

The largest guru shareholder of the company is Barrow, Hanley, Mewhinney & Strauss with 12.23% of outstanding shares, followed by Simons’ firm with 0.42% and Chuck Royce (Trades, Portfolio) with 0.04%.

Bristol-Myers

The investment fund cut its holding of Bristol-Myers Squibb Company (BMY) by 1.01%. The trade had an impact of -0.11% on the portfolio.

f575ae76508e67edd9ee57ed6966c035.png

The company, which provides drugs for cardiovascular, oncology and immune disorders, has a market cap of $134.56 billion and an enterprise value of $163.84 billion.

GuruFocus gives the company a profitability and growth rating of 8 out of 10. The return on equity of 3.17% and return on assets of 1.17% are underperforming 50% of companies in the drug manufacturers industry. Its financial strength is rated 5 out of 10 with a cash-debt ratio of 0.39.

The largest guru shareholder of the company is Simons’ firm with 2.92% of outstanding shares, followed by Dodge & Cox with 1.60% and the Vanguard Health Care Fund (Trades, Portfolio) with 1.55%.

Disclosure: I do not own any stocks mentioned.

Read more here:

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

About the author:

Tiziano Frateschi
You can read about me on www.theextraincome.info, which gives suggestions on position trading.

Visit Tiziano Frateschi's Website


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by Tiziano Frateschi


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)